Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function

Clinical trial NCT07422857 · RECRUITING

Trial details

NCT number: NCT07422857
Sponsor: JYAMS PET Research & Development Limited
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia

Start date: 2026-01-22
Primary completion: 2026-12-01
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.